Leukemia prevention and long-term survival of AKR mice transplanted with MHC-matched or MHC-mismatched bone marrow
The current studies were designed to evaluate the effectiveness of marrow transplantation within and outside the major histocompatibility complex (MHC) on the long-term survival and occurrence of spontaneous leukemia in AKR mice. AKR mice, which were lethally irradiated and received MHC-matched marrow from CBA/J mice (CBA----AKR), never developed leukemia and were alive and remained healthy for up to 280 days post-transplant. These long-term surviving chimeras possessed substantial immune vigor when both cell-mediated and humoral responses were tested. Lethally irradiated AKR mice, which had received MHC-mismatched marrow (anti-Thy-1.2 treated or nontreated) from C57BL/6J mice (B6----AKR), never developed leukemia and survived up to 170 days post-transplant. However, both groups of these chimeras began dying 180 to 270 days post-transplant due to a disease process which could not be readily identified. Histological analysis of B6----AKR chimeras revealed severe lymphoid cell depletion in thymus and spleen; however, none of these chimeras exhibited classical features of acute graft versus host disease. Concanavalin A mitogenesis, primary antibody responses to sheep red blood cells and the production of interleukin 2 (IL-2) were suppressed in B6----AKR chimeras. IL-2 treatment of B6----AKR chimeras was shown to partially correct these deficiencies without stimulating mixed lymphocyte responsiveness to donor or host lymphocytes. These studies indicate that the use of MHC-mismatched marrow for the prevention of spontaneous AKR leukemia may rely on augmentative IL-2 therapy for complete immune reconstitution of leukemia-free chimeras.
- Research Organization:
- Univ. of Central Florida, Orlando
- OSTI ID:
- 6847061
- Journal Information:
- Cell. Immunol.; (United States), Vol. 2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Thymic repopulation following intrathymic injection of mouse bone marrow cells in MHC matched and mismatched recipients
Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens
Related Subjects
BONE MARROW
TRANSPLANTS
LEUKEMIA
THERAPY
LETHAL IRRADIATION
MICE
SURVIVAL TIME
ANIMAL TISSUES
ANIMALS
BODY
DISEASES
HEMATOPOIETIC SYSTEM
HEMIC DISEASES
IRRADIATION
MAMMALS
NEOPLASMS
ORGANS
RODENTS
TISSUES
VERTEBRATES
560152* - Radiation Effects on Animals- Animals